Literature DB >> 16897351

Drug use and medication adherence among HIV-1 infected individuals.

Charles H Hinkin1, Terry R Barclay, Steven A Castellon, Andrew J Levine, Ramani S Durvasula, Sarah D Marion, Hector F Myers, Douglas Longshore.   

Abstract

This longitudinal study examined the impact of drug use and abuse on medication adherence among 150 HIV-infected individuals, 102 who tested urinalysis positive for recent illicit drug use. Medication adherence was tracked over a 6-month period using an electronic monitoring device (MEMS caps). Over the 6-month study drug-positive participants demonstrated significantly worse medication adherence than did drug-negative participants (63 vs. 79%, respectively). Logistic regression revealed that drug use was associated with over a fourfold greater risk of adherence failure. Stimulant users were at greatest risk for poor adherence. Based upon within-participants analyses comparing 3-day adherence rates when actively using versus not using drugs, this appears to be more a function of state rather than trait. These data suggest that it is the acute effects of intoxication, rather than stable features that may be characteristic of the drug-using populace, which leads to difficulties with medication adherence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16897351      PMCID: PMC2867605          DOI: 10.1007/s10461-006-9152-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  55 in total

Review 1.  Adherence to HIV combination therapy.

Authors:  M A Chesney; M Morin; L Sherr
Journal:  Soc Sci Med       Date:  2000-06       Impact factor: 4.634

2.  Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens.

Authors:  A L Gifford; J E Bormann; M J Shively; B C Wright; D D Richman; S A Bozzette
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-15       Impact factor: 3.731

3.  Drug use, self report and urinalysis.

Authors:  B Kilpatrick; M Howlett; P Sedgwick; A H Ghodse
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

4.  A comparison study of multiple measures of adherence to HIV protease inhibitors.

Authors:  H Liu; C E Golin; L G Miller; R D Hays; C K Beck; S Sanandaji; J Christian; T Maldonado; D Duran; A H Kaplan; N S Wenger
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

5.  Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Authors:  E L Murphy; A C Collier; L A Kalish; S F Assmann; M F Para; T P Flanigan; P N Kumar; L Mintz; F R Wallach; G J Nemo
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

6.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

Authors:  D R Bangsberg; F M Hecht; E D Charlebois; A R Zolopa; M Holodniy; L Sheiner; J D Bamberger; M A Chesney; A Moss
Journal:  AIDS       Date:  2000-03-10       Impact factor: 4.177

7.  Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Authors:  M R DiMatteo; H S Lepper; T W Croghan
Journal:  Arch Intern Med       Date:  2000-07-24

8.  Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; M Leonido-Yee; D Franceschi; M J Sedler; S J Gatley; R Hitzemann; Y S Ding; J Logan; C Wong; E N Miller
Journal:  Am J Psychiatry       Date:  2001-03       Impact factor: 18.112

9.  Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

Authors:  P T Nieuwkerk; M A Sprangers; D M Burger; R M Hoetelmans; P W Hugen; S A Danner; M E van Der Ende; M M Schneider; G Schrey; P L Meenhorst; H G Sprenger; R H Kauffmann; M Jambroes; M A Chesney; F de Wolf; J M Lange
Journal:  Arch Intern Med       Date:  2001-09-10

10.  The validity of adult arrestee self-reports of crack cocaine use.

Authors:  N T Lu; B G Taylor; K J Riley
Journal:  Am J Drug Alcohol Abuse       Date:  2001-08       Impact factor: 3.829

View more
  176 in total

1.  Alcohol use accelerates HIV disease progression.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Sabrina Sales; John Bryan Page; Adriana Campa
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

Review 2.  A systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamine.

Authors:  Radha Rajasingham; Matthew J Mimiaga; Jaclyn M White; Megan M Pinkston; Rachel P Baden; Jennifer A Mitty
Journal:  AIDS Patient Care STDS       Date:  2011-11-09       Impact factor: 5.078

Review 3.  Cell Phone-Based and Adherence Device Technologies for HIV Care and Treatment in Resource-Limited Settings: Recent Advances.

Authors:  Jeffrey I Campbell; Jessica E Haberer
Journal:  Curr HIV/AIDS Rep       Date:  2015-12       Impact factor: 5.071

4.  Patterns of drug use and HIV infection among adults in a nationally representative sample.

Authors:  Stephanie Shiau; Stephen M Arpadi; Michael T Yin; Silvia S Martins
Journal:  Addict Behav       Date:  2017-01-07       Impact factor: 3.913

5.  Antiretroviral therapy adherence and self-efficacy among people living with HIV and a history of drug use in Vietnam.

Authors:  Li Li; Chunqing Lin; Sung-Jae Lee; Le Anh Tuan; Nan Feng; Nguyen Anh Tuan
Journal:  Int J STD AIDS       Date:  2017-03-03       Impact factor: 1.359

6.  Event-level relationship between methamphetamine use significantly associated with non-adherence to pharmacologic trial medications in event-level analyses.

Authors:  Keith A Hermanstyne; Glenn-Milo Santos; Eric Vittinghoff; Deirdre Santos; Grant Colfax; Phillip Coffin
Journal:  Drug Alcohol Depend       Date:  2014-08-05       Impact factor: 4.492

7.  HIV-infected individuals who use alcohol and other drugs, and virologic suppression.

Authors:  Seonaid Nolan; Alexander Y Walley; Timothy C Heeren; Gregory J Patts; Alicia S Ventura; Meg M Sullivan; Jeffrey H Samet; Richard Saitz
Journal:  AIDS Care       Date:  2017-05-17

8.  The importance of how research participants think they are perceived: results from an electronic monitoring study of antiretroviral therapy in Uganda.

Authors:  Jeffrey I Campbell; Angella Musiimenta; Bridget Burns; Sylvia Natukunda; Nicholas Musinguzi; Jessica E Haberer; Nir Eyal
Journal:  AIDS Care       Date:  2018-12-09

9.  The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.

Authors:  Yuehan Zhang; Tracey E Wilson; Adebola Adedimeji; Daniel Merenstein; Joel Milam; Jennifer Cohen; Mardge Cohen; Elizabeth T Golub
Journal:  AIDS Behav       Date:  2018-03

10.  Correlates of Recent HIV Testing Among Transgender Women in Greater Kuala Lumpur, Malaysia.

Authors:  Ronnye Rutledge; Olga Morozova; Britton A Gibson; Frederick L Altice; Adeeba Kamarulzaman; Jeffrey A Wickersham
Journal:  LGBT Health       Date:  2018-11-27       Impact factor: 4.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.